In agreement, such scenario was supported by our observations that stabilized AEG-1 (AEG-1C75A) enhances its binding to SND1 and activates RISC activity for the downregulation of these tumor suppressors and HCC progression (Figure 2, Figure 4 and Figure 5). The gene discussed is SND1; the disease is hepatocellular carcinoma.